Pacira BioSciences, Inc.
USD25.28
+0.19 (+0.77%)
CEO
Frank D. Lee
IPO Date
2011-02-03
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Country
US
Open
$26.00
Prev. Close
$25.09
Day Low
$25.14
Day High
$26.21
52W Low
$18.80
52W High
$27.64
Market Cap
$0.99B
Volume
0.05M
| -8.8 |
| 31 Dec 2023 | FY | 72.6% | 6.2% | 4.8% | 2.7% | 0.67 | 5.24 | 37.2 |
| 31 Dec 2022 | FY | 70.1% | 2.4% | 2.1% | 0.9% | 0.99 | 3.37 | 110.5 |
| 31 Dec 2021 | FY | 74.1% | 7.8% | 5.7% | 2.0% | 1.55 | 1.66 | 63.4 |
| 31 Dec 2020 | FY | 72.7% | 33.9% | 23.5% | 11.4% | 0.87 | 2.57 | 17.5 |
| 31 Dec 2019 | FY | 74.7% | -2.6% | -3.1% | -1.3% | 0.99 | 3.79 | -170.7 |
| 31 Dec 2018 | FY | 74.3% | -0.1% | -0.1% | -0.1% | 0.91 | 7.88 | -3736.7 |
| 31 Dec 2017 | FY | 69.3% | -14.9% | -15.2% | -6.8% | 0.99 | 6.96 | -42.6 |
| 31 Dec 2016 | FY | 60.2% | -13.7% | -17.3% | -9.7% | 0.50 | 5.42 | -31.7 |
| 167.9 |
| 30 Sept 2025 | Q3 | 80.9% | 3.0% | 0.7% | 0.4% | 0.58 | 5.26 | 52.2 |
| 30 Jun 2025 | Q2 | 77.4% | -2.7% | -0.6% | -0.3% | 0.83 | 2.38 | -56.0 |
| 31 Mar 2025 | Q1 | 79.7% | 2.8% | 0.6% | 0.3% | 0.80 | 2.41 | 59.7 |
| 31 Dec 2024 | Q4 | 78.7% | 8.6% | 2.1% | 1.0% | 0.82 | 2.40 | 13.6 |
| 30 Sept 2024 | Q3 | 76.9% | -85.1% | -19.1% | -9.4% | 0.86 | 2.25 | -1.2 |
| 30 Jun 2024 | Q2 | 75.1% | 10.6% | 2.1% | 1.1% | 0.74 | 6.82 | 17.4 |
| 31 Mar 2024 | Q1 | 71.6% | 5.4% | 1.0% | 0.6% | 0.65 | 5.81 | 37.7 |
| 31 Dec 2023 | Q4 | 73.7% | 13.7% | 2.9% | 1.6% | 0.67 | 5.24 | 15.7 |